RxDoctor Payments Data

Roger Freedman, MD

Clinical Cardiac Electrophysiology · Salt Lake City, UTNPI 1790866580

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.8%), speaking fees and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Cook Incorporated at 46.3% of the total. Reporting peaked in 2019 at $48,536 and has fallen 85.4% since, to $7,099 in 2025.

$176,908in general payments, 2019–2025

Across 203 payments — averaging $871.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$82K
  • Abbott$70K
  • Merit Medical Systems Inc$11K
  • Cook Research Incorporated$7K
  • Cook Medical LLC$6K
  • Medtronic$896
  • plus $178 from 2 others
$163,488in research payments, 2019–2025

Across 61 payments — averaging $2680.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$100K
  • Abbott$34K
  • Boston Scientific$29K

What the payments were for

  • Consulting fees$88,04850%
  • Speaking & faculty fees$68,46039%
  • Travel & lodging$7,1954%
  • Food & beverage$3,2912%
  • Education$9,9146%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cook Incorporated31$81,959
Abbott86$70,396
Merit Medical Systems Inc8$10,697
Cook Research Incorporated9$7,070
Cook Medical LLC34$5,711
Medtronic(2 entities)26$896
Boston Scientific7$152
Cvrx, Inc.2$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$176,908 in reported general payments places this provider in the 85th percentile of 29 clinical cardiac electrophysiology providers in Utah.

See all clinical cardiac electrophysiology providers in Utah

Medicare billing

Part B allowed, 2024
$227,835
Medicare patients
1,684
Services billed
3,339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$26,919
Propranolol Hcl ErPropranolol Hcl13$513
Amiodarone Hcl11$198

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →